Gregory Quatrino, MD
Surgery · Mobile, ALNPI 1497016794
Payments from drug & device makers
Across 39 payments — averaging $57.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Baxter Healthcare$121
- Trevena, Inc.$64
- Medtronic$55
- Integra Lifesciences Corporation$43
- TELA Bio, Inc.$39
- plus $382 from 19 others
What the payments were for
- Food & beverage$74033%
- Education$1,50067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $1,535 |
| Baxter Healthcare | 5 | $121 |
| Trevena, Inc. | 3 | $64 |
| Medtronic | 2 | $55 |
| Integra Lifesciences Corporation | 2 | $43 |
| TELA Bio, Inc. | 3 | $39 |
| TEI Biosciences Inc | 2 | $35 |
| Kerecis Limited | 1 | $34 |
| Dilon Technologies, Inc. | 1 | $26 |
| Covidien LP | 1 | $25 |
| Getinge USA Sales, LLC | 1 | $24 |
| THD America, Inc. | 2 | $23 |
| Acell, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Vertex | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Polynovo North America LLC | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
| Standard Bariatrics, Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $13 |
| Davol Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
How this compares
$2,240 in reported general payments places this provider in the 50th percentile of 382 surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 23 | $939 |
| Neomycin Sulfate | 41 | $247 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $181 |
| Metronidazole | 17 | $44 |
Paid to pharmacies, not to this prescriber.
Other surgery in Mobile
- Forrest RingoldMobile$678K
- William RichardsMobile$78K
- Daniel McMahonMobile$57K
- Andrew BrightMobile$37K
- Ernest BurchMobile$30K
- Daran MasonMobile$21K
- Christopher DyasMobile$18K
- Edward OttsMobile$18K
- Daniel LaneMobile$16K
- Dusty SmithMobile$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.